Skip to content

Application of Fluid Management Guided by Dynamic Assessment of Fluid Responsiveness in Patients with Sepsis Complicated by Acute Heart Failure

Application of Fluid Management Guided by Dynamic Assessment of Fluid Responsiveness in Patients with Sepsis Complicated by Acute Heart Failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120736
Enrollment
Unknown
Registered
2026-03-19
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis complicated by acute heart failure

Interventions

Control group:Traditional Fluid Management
Intervention group:Dynamic Fluid Responsiveness Assessment-Guided Fluid Management

Sponsors

Emergency General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age>=18 years; 2. Meet the diagnostic criteria for sepsis combined with acute heart failure; 3. Patient or their family has signed the informed consent form and is willing to participate in this study; 4. Expected hospital stay =48 hours to allow sufficient observation and intervention; 5. Patient is under mechanical ventilation and without arrhythmia, meeting the applicable conditions for non-invasive hemodynamic monitoring equipment.

Exclusion criteria

Exclusion criteria: 1.Have severe valvular heart disease (such as severe mitral or aortic stenosis) or other congenital heart diseases that may affect the implementation of hemodynamic monitoring and fluid management strategies; 2.Have severe liver and kidney failure (such as Child-Pugh Class C cirrhosis or end-stage renal disease), the complexity of which may interfere with the assessment of sepsis complicated by acute heart failure and the judgment of treatment efficacy. 3.Have an active malignancy with an expected survival time of less than 3 months, where the focus of treatment is more likely to be on palliative care rather than active interventions such as fluid resuscitation; 4.Presence of severe coagulation dysfunction (e.g., international normalized ratio [INR] > 3.0 or activated partial thromboplastin time [APTT] > 100 seconds), which may increase the risk of invasive procedures (such as central venous catheter insertion), thereby affecting the implementation of fluid management; 5.The patient or their legal guardians refuse to participate in this study or fail to comply with the various monitoring and intervention measures during the study process;

Design outcomes

Primary

MeasureTime frame
APACHE II score;Hemodynamic parameters;Lactate clearance rate;

Secondary

MeasureTime frame
28-day all-cause mortality; SOFA score;

Countries

China

Contacts

Public ContactCui Juan

Emergency General Hospital

wandeweiying@163.com+86 10 8426 2610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026